Research from Fudan University, Department of Oncology reveals new findings on non-small cell lung cancer therapy

New investigation results, 'A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer,' are detailed in a study published in Lung Cancer. According to a study from Shanghai, People's Republic of China, "' Since the debate still exists whether cisplatin-based and carboplatin-based chemotherapy are equally effective for advanced non-small-cell lung cancer (NSCLC), a meta-analysis of trials was performed to compare the cisplatin-based with carboplatin-based regimens in first line chemotherapy of advanced NSCLC. A literature search was performed in PubMed database, the Cochrane Central Register of...

Want to see the full article?

• Purchase this article for only $3.00